SBX-2022
N/A
Report date: 2023/01/02 17:06:09
Base Information
Drug NameSBX-2022
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusIND
Highest Status in ChinaN/A
Originator CompaniesStramsen Biotech Inc
China Registration ClassN/A
Develop Information
Other Information
ATC CodeN/A
Related LinksN/A